OpenURL Connection Search

Select item for more details and to access through your institution.

Three-yr safety and efficacy of everolimus and low-dose cyclosporine in de novo pediatric kidney transplant patients.
Published in:
Pediatric Transplantation, 2014, v. 18, n. 4, p. 350, doi. 10.1111/petr.12261
By:
- Ferraresso, Mariano;
- Belingheri, Mirco;
- Ginevri, Fabrizio;
- Murer, Luisa;
- Dello Strologo, Luca;
- Cardillo, Massimo;
- Parodi, Angelica;
- Ghirardo, Giulia;
- Guzzo, Isabella;
- Innocente, Annalisa;
- Ghio, Luciana
Publication type:
Article
Failure to remove de novo donor‐specific HLA antibodies is influenced by antibody properties and identifies kidney recipients with late antibody‐mediated rejection destined to graft loss – a retrospective study.
Published in:
Transplant International, 2019, v. 32, n. 1, p. 38, doi. 10.1111/tri.13325
By:
- Cioni, Michela;
- Nocera, Arcangelo;
- Tagliamacco, Augusto;
- Basso, Sabrina;
- Innocente, Annalisa;
- Fontana, Iris;
- Magnasco, Alberto;
- Trivelli, Antonella;
- Klersy, Catherine;
- Gurrado, Antonella;
- Ramondetta, Miriam;
- Boghen, Stella;
- Catenacci, Laura;
- Verrina, Enrico;
- Garibotto, Giacomo;
- Ghiggeri, Gian Marco;
- Cardillo, Massimo;
- Ginevri, Fabrizio;
- Comoli, Patrizia
Publication type:
Article
Serum complement inactivation unveiled prepregnancy donor-specific HLA antibodies leading to postpartum kidney graft loss.
Published in:
Transplant International, 2015, v. 28, n. 5, p. 623, doi. 10.1111/tri.12521
By:
- Nocera, Arcangelo;
- Cioni, Michela;
- Tagliamacco, Augusto;
- Comoli, Patrizia;
- Innocente, Annalisa;
- Ceriolo, Paola;
- Cardillo, Massimo;
- Ginevri, Fabrizio
Publication type:
Article
De Novo Donor-Specific HLA Antibodies Developing Early or Late after Transplant Are Associated with the Same Risk of Graft Damage and Loss in Nonsensitized Kidney Recipients.
Published in:
2017
By:
- Cioni, Michela;
- Nocera, Arcangelo;
- Innocente, Annalisa;
- Tagliamacco, Augusto;
- Trivelli, Antonella;
- Basso, Sabrina;
- Quartuccio, Giuseppe;
- Fontana, Iris;
- Magnasco, Alberto;
- Drago, Francesca;
- Gurrado, Antonella;
- Guido, Ilaria;
- Compagno, Francesca;
- Garibotto, Giacomo;
- Klersy, Catherine;
- Verrina, Enrico;
- Ghiggeri, Gian Marco;
- Cardillo, Massimo;
- Comoli, Patrizia;
- Ginevri, Fabrizio
Publication type:
journal article

Found: 4

Three-yr safety and efficacy of everolimus and low-dose cyclosporine in de novo pediatric kidney transplant patients.

Failure to remove de novo donor‐specific HLA antibodies is influenced by antibody properties and identifies kidney recipients with late antibody‐mediated rejection destined to graft loss – a retrospective study.

Serum complement inactivation unveiled prepregnancy donor-specific HLA antibodies leading to postpartum kidney graft loss.

De Novo Donor-Specific HLA Antibodies Developing Early or Late after Transplant Are Associated with the Same Risk of Graft Damage and Loss in Nonsensitized Kidney Recipients.